[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625360":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":36,"centralContacts":37,"locations":36,"responsibleParty":47,"collaborators":36,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":53,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":36,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":72,"overallStatus":74,"whyStopped":36,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":36},{"fullName":5,"class":6},"Sheikh Zayed Federal Postgraduate Medical Institute","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Anterior Nasal Packing","ACTIVE_COMPARATOR","Patients receiving anterior nasal packing for acture epistaxis",[13],"Procedure: Anterior Nasal Packing",{"label":15,"type":10,"description":16,"interventionNames":17},"Greater Palatine Foramen Block (GPFB)","Patients receiving GPFB to achive hemostasis in acute epistaxis",[18],"Procedure: Greater Palatine Foramen Block with 2% xylocaine with adrenaline",[20,28],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"PROCEDURE","Greater Palatine Foramen Block with 2% xylocaine with adrenaline","Patients allocated to this group will receive a greater palatine foramen block using a local anaesthetic agent (2% i.e. 20mg\u002FdL Inj. Lidocaine with adrenaline) administered at the greater palatine foramen under aseptic conditions. Patients will be monitored for local anaesthetic as well as GPF block-related adverse effects. Hemostasis will be assessed following the procedure.",[15],[26,27],"greater palatine foramen block","GPFB",{"type":21,"name":9,"description":29,"armGroupLabels":30,"otherNames":31},"Patients allocated to this group will receive anterior nasal packing using standard non-absorbable nasal packs following institutional protocol. Packs will remain in situ for 24-72 hours, unless earlier removal is clinically indicated.",[9],[32,33,34,35],"ANP","nasal packing","BIPP packing","merocel",null,[38,43],{"name":39,"role":40,"phone":41,"phoneExt":36,"email":42},"WIZRA FAIZ, MBBS","CONTACT","+92 3219458432","wizrafaiz1999@gmail.com",{"name":44,"role":40,"phone":45,"phoneExt":36,"email":46},"Sarfraz Latif, MBBS, FCPS, DLO","+92 321 4467702","drsarfrazlatif@gmail.com",{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":36,"oldOrganization":36},"PRINCIPAL_INVESTIGATOR","Tahira Shaukat","Clinical Professor Head of Otolaryngology & Head and Neck Surgery","100625360","management-of-epistaxis-comparing-nasal-packing-versus-greater-palatine-foramen-block-100625360",false,"NCT07421622","Management of Epistaxis Comparing Nasal Packing Versus Greater Palatine Foramen Block","A Pilot Randomized Controlled Trial in Management of Epistaxis Comparing Nasal Packing Versus Greater Palatine Foramen Block","ANPvsGPF block","Inclusion Criteria:\n\n* Presentation with active anterior epistaxis\n* Failure of initial conservative measures (e.g., nasal compression and topical vasoconstrictors)\n* Ability to provide informed consent and those who consent for the study.\n\nExclusion Criteria:\n\n* Suspected or confirmed posterior epistaxis\n* Known bleeding disorders or platelet count \\\u003C50,000\u002Fmm³\n* Use of anticoagulants with supratherapeutic INR\n* Known allergy to local anaesthetic agents","ALL","18 Years","70 Years",{"count":63,"type":64},40,"ESTIMATED","INTERVENTIONAL",[67],"NA","The goal of this pilot randomized controlled trial is to compare pain relief efficacy while using nasal packing versus greater palatine foramen block (GPFB) in the management of acute episodes of epistaxis. The main questions it aims to answer are: Does GPFB have less potential to inflict pain when dealing with hemostasis with epistaxis, utilizing a pre-validated 10-point visual analog scale (VAS)? Was hemostasis management more effective in either technique? Researchers will compare anterior nasal packing to greater palatine foramen block using 2% xylocaine with adrenaline.\n\nPatients will receive any of the hemostatic interventions at the time of the acute epistaxis episode.\n\nThe questionnaire will be administered 24 hours post-intervention.",[70,71],"Epistaxis Nosebleed","Greater Palatine Foramen",[73],"epistaxis","NOT_YET_RECRUITING","2026-02-20",{"date":77,"type":78},"2026-02-24","ACTUAL",{"date":80,"type":64},"2026-03-01",{"date":82,"type":64},"2027-02-28",{"name":5,"class":6}]